Merck May Face Criminal Probe On Vioxx: Report

Law360, New York (February 1, 2008, 12:00 AM EST) -- As Merck & Co. Inc.'s $4.85 billion Vioxx civil settlement moves closer to reality, the company may now be facing a criminal investigation. A federal grand jury has launched a probe into the sales and marketing practices for Vioxx, the Wall Street Journal reported Friday.

Citing an unnamed source, the paper reported that the health care fraud unit of the U.S. Attorney's Office for the District of Massachusetts is looking into whether Merck encouraged doctors to prescribe the painkiller for uses other than those it was...
To view the full article, register now.